CIK: 1377952 - Address: C/O Zentalis Pharmaceuticals, Inc., 1359 Broadway, Suite 1710, New York, NY 10018
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/5/22 18:52
4/4/22
ZNTLZentalis Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,04750.010-21-12,592D
3/3/22 17:11
3/1/22
ZNTLZentalis Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,04749.980-21-12,613D
2/14/22 21:08
2/14/22
ZNTLZentalis Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.d-23850.230-502,634D
2/3/22 20:03
2/1/22
ZNTLZentalis Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,21057.770-21-12,588D
1/5/22 17:49
1/3/22
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,66279.380-21-12,609D
12/2/21 19:16
12/1/21
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,62177.380-21-12,645M
11/2/21 19:24
11/1/21
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS.m-1,69580.960-21-12,666D
10/4/21 21:15
10/4/21
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS-1,77866.330-27-12,687D
9/2/21 19:32
9/1/21
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOS-1,80967.500-27-12,714D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact